<DOC>
	<DOCNO>NCT00724256</DOCNO>
	<brief_summary>The purpose study evaluate efficacy oral ceftibuten 7 day versus 10 day acute pyelonephritis child . The main hypothesis ceftibuten 7 day inferior ceftibuten 10 day rate renal scar 6-12 month .</brief_summary>
	<brief_title>Short-term Antibiotic Therapy Pyelonephritis Childhood</brief_title>
	<detailed_description>Acute pyelonephritis one common serious bacterial infection childhood , particularly young child , estimate prevalence febrile infant 5.3 % . It consider important risk factor development renal scarring , renal insufficiency . More recently long term outcome pyelonephritis ameliorate , probably prompt diagnosis therapy , importance urinary tract infection risk factor renal insufficiency question . Nevertheless , optimal type duration antibiotic therapy acute uncomplicated pyelonephritis child establish yet . There general agreement child dehydrate , unable drink , sepsis possible , admitted hospital intravenous antibiotic treatment . Outside condition , evidence suggest child acute pyelonephritis treat effectively cefixime , ceftibuten amoxycillin/clavulanic acid . give orally ( 1 ) . A recently update Cochrane review antibiotic treatment acute pyelonephritis child identify twenty three study ( 3407 child ) . No significant difference find persistent renal damage six 12 month ( 824 child : RR 0.80 , 95 % CI 0.50 1.26 ) duration fever ( 808 child : WMD 2.05 , 95 % CI -0.84 4.94 ) oral antibiotic therapy ( 10 14 day ) IV therapy ( 3 day ) follow oral therapy ( 10 day ) . Similarly significant difference persistent renal damage ( 3 study , 341 child : RR 1.13 , 95 % CI 0.86 1.49 ) find IV therapy ( 3 4 day ) follow oral therapy IV therapy 7 14 day . Authors conclude child acute pyelonephritis treat effectively oral antibiotic ( cefixime , ceftibuten amoxycillin/clavulanic acid ) short course ( 2 4 day ) IV therapy follow oral therapy . Oral treatment also easy use require admission hospital , lead reduce cost . Nevertheless , exact duration oral therapy establish . Current guideline recommend 7-14 day course broad-spectrum antibiotic capable reach significant renal level . The objective study evaluate oral ceftibuten 7 day equally effective oral ceftibuten 10 day acute pyelonephritis child . This non-inferiority randomise control trial determine whether short term therapy ceftibuten ( 7 day ) therapeutically similar long term therapy ( 10 day ) , measure major outcome prevalence renal scar .</detailed_description>
	<mesh_term>Pyelonephritis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ceftibuten</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Children age 1 month 5 year , first episode pyelonephritis . Children le 1 month , old 5 year . Relapse pyelonephritis . Sepsis and/or vomiting , condition 's impossible administer oral therapy . Allergy ceftibuten . Previous antibiotic therapy infection . Long term antibiotic prophylaxis antibiotic class , laboratory antibiotic resistance show . Children uncontrolled disease . Complicated pyelonephritis ( abscess ) .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Pyelonephritis .</keyword>
	<keyword>Urinary Tract Infections .</keyword>
	<keyword>Children .</keyword>
	<keyword>Randomised controlled trial .</keyword>
	<keyword>Therapy .</keyword>
	<keyword>Ceftibuten .</keyword>
</DOC>